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Epidemiological studies of DNA methylation in airway disease have largely been conducted 
using blood or buccal samples. However, given tissue specificity of DNA methylation, these 
surrogate tissues may not allow reliable inferences about methylation in the lung. 
Objective 
To compare the pattern of DNA methylation in blood, buccal and nasal epithelial cells to that in 
airway epithelial cells from children. 
Methods  
Samples of blood, and buccal, nasal and airway epithelium were obtained from six children 
undergoing elective anaesthesia for adenotonsillectomy. DNA methylation was assessed at 
450,000 sites using the Illumina HumanMethylation450 array. 
Results 
Eighteen samples from all sites were suitable for analysis. Hierarchical clustering demonstrated 
that the methylation profile in nasal epithelium was most representative of that in airway 
epithelium; the profile in buccal cells was moderately similar; and that in blood was least similar.   
Conclusion 
DNA methylation in blood poorly reflects methylation in airway epithelium. Future 
epidemiological studies of DNA methylation and airway diseases should consider measurement 




DNA methylation is tissue specific, and primary tissue may not be available for large scale 
studies of epigenetic markers in airways disease. We sought to compare nasal, buccal, airway 
and blood DNA methylation in order to establish a best proxy for airway cells. We demonstrate 






There is growing interest in the role of epigenetic control of gene expression in the lung [1], and 
in the likely importance of epigenetic mechanisms in the aetiology of asthma [2-4].  
Consequently there have been calls to include epigenetics in epidemiological studies of asthma 
[5] and evidence has been gradually accumulating to implicate altered DNA methylation, the 
most readily studied epigenetic process in population-based studies, in childhood asthma.  For 
example, differential methylation has been reported in relation to childhood wheezing and 
asthma [6, 7], and to risk factors such as maternal smoking in pregnancy [8, 9], although 
epidemiological data confirming whether the associations between early life risk factors and 
asthma are mediated through altered DNA methylation are still sparse.  Experimental evidence in 
mouse models has provided further evidence for a potential role of altered DNA methylation in 
asthma [10-12]. 
 
Epidemiological studies of epigenetics and asthma to date have tended to measure DNA 
methylation predominantly using DNA extracted from peripheral blood leukocytes [6, 7, 9], and 
sometimes buccal samples [8], as these sources of DNA are readily accessible and direct lower 
airway sampling is generally not feasible in population-based studies.  A potential difficulty with 
this approach is that DNA methylation tends to be highly tissue-specific [13] and even cell-type 
specific [14], and hence these tissues may not allow reliable inferences about methylation in the 
lung.  It has been argued that methylation measured in buccal DNA samples may better reflect 
methylation in the lung than methylation measured in peripheral blood leukocyte DNA [15], and 
we recently showed that buccal samples are likely to be a more informative surrogate tissue than 
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blood for epigenome-wide association studies (EWAS) of non-blood based diseases/phenotypes, 
especially those linked to epithelial disorders such as paediatric eosinophilic oesophagitis [16].  
However, the most informative proxy tissue may be nasal epithelium, given that the nose and 
airways form a continuous tract, and that nasal epithelial cells have been used as surrogates for 
bronchial epithelial cells in studies of airway inflammation [17].  To date, no comparison has 
been made between the DNA methylation profiles of airway and nasal epithelial cells, buccal 
cells and blood to confirm the best proxy tissue for epidemiological studies of airway diseases.  
We have therefore sought to establish which proxy tissue exhibits the closest pattern of 
epigenome-wide DNA methylation to that of airway epithelial cells.  Our a priori hypothesis was 
that methylation profiles from nasal epithelial cells would show a greater similarity than those 










In order to obtain uncontaminated airway cells, children requiring elective endotracheal 
intubation were recruited to the study.  Six children (four female, two male) aged 5-13 years 
undergoing elective tonsillectomy or adenotonsillectomy were recruited from the Ear, Nose and 
Throat clinic at the Royal London Hospital, three of whom had doctor diagnosed asthma. 
Children with a respiratory condition other than asthma were excluded. Ethical approval was 
obtained from the National Research Ethics Service Committee London - Riverside (REC 
11/LO/1579), and parents or carers consented for study procedures. 
 
Sampling 
Samples from 4 tissue sites (airway, nasal, buccal and blood) were obtained.  Buccal cells were 
collected pre-operatively using swabs (Isohelix SK-2S, Cell Projects, Kent, UK). Immediately 
following intubation, tracheal epithelial cells were collected by performing blind brushings via 
the endotracheal tube using a 2mm cytology brush (BC-202D-5010, Olympus KeyMed, Essex, 
UK). This has been shown to be an effective and safe method in children when bronchoscopy is 
not feasible [18, 19]. Nasal epithelial cells were obtained by directly observed curettage of the 
inferior nasal turbinates (Rhino-Pro® Nasal Mucosal Curette, Arlington Scientific, Utah, USA). 
Peripheral blood was obtained by venesection and mixed with EDTA (BD vacutainer, Becton 






Measurement of DNA methylation  
DNA Extraction and Quality control 
Upon receipt, buccal swabs were treated as per the Isohelix DNA Isolation Kit DDK-50 protocol 
Part A, until appropriate numbers for extraction had been received.  Nasal mucosal samples and 
airway brushings were immersed in 0.9% sodium chloride and frozen at -80oC. After thawing, 
tubes were vortexed to loosen collected cells, probes and brushes were removed, and the 
resulting cell suspension was then centrifuged at 3,500 RCF for 10 minutes in a bench-top 
centrifuge to pellet the cells. The supernatant was removed and DNA extraction of buccal swabs, 
nasal and airway samples was carried out as in the Isohelix protocol (beginning at Part B for 
buccal swabs), with the optional step 6 included, and the elution volume used was 30µl. 
Blood samples were stored at -20° C until extraction. Extraction was performed using a salting 
out procedure [20]. Briefly, blood samples were defrosted overnight before 40mls of cold water 
were added to lyse red cells, followed by centrifugation at 3000 RCF for 20 minutes at 4° C to 
precipitate white cells. Supernatant was discarded and the pellet re-suspended in 40mls solution 
1 (0.32M Sucrose, 0.01M Tris-Cl, pH 7.6, 0.005M MgCl2, 1%TRitonX100, 0.02 Sodium Azide).  
Samples were centrifuged at 3000 RCF for 20 minutes at 4° C.  The supernatant was discarded 
and the pellet re-suspended in 30mls solution 1.  Tubes were centrifuged at 3000 RCF for 20 
minutes at 4° C and the pellet re-suspended in 11mls of Solution 2 (0.05M Tris-Cl, pH 8, 0.02M 
EDTA, pH 8, 2%SDS).  Samples were digested with 1mg Proteinase K overnight at 37° C 
followed by protein precipitation with saturated 4 mls NaCl solution.  Protein was precipitated 
by centrifugation at 3500 RCF for 20min at 4°C and DNA was precipitated with 3x volume 
100% Ethanol.  DNA quantity and purity were measured using a Nanodrop8000 
spectrophotometer (Thermofisher Scientific, Delaware, USA). A Qubit® 2.0 fluorometer 
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(LifeTechnologies, Paisley, United Kingdom) with the Qubit® dsDNA HS kit was used to 
quantify intact double-stranded DNA. Samples were also checked for RNA contamination by an 
Agilent RNA 6000 Nano kit on the Agilent 2100 Bioanalyser (Agilent Technologies, California, 
USA). 
 
Bisulphite conversion and Quality control 
Any sample with less than 500ng total DNA quantity was excluded from further analysis.  500ng 
of DNA were bisulphite converted using the Zymo EZ-96 DNA Methylation Kit D5004 (Zymo 
Research Corp, California, USA). Bisulphite conversion was performed as per manufacturer’s 
instructions but with incubation conditions recommended by Illumina for the Infinium® 
Methylation arrays. The resulting quantity of single-stranded, converted sample was measured 
using the Nanodrop with the RNA setting. An initial QC of the bisulfite conversion efficiency 
suggested one of the samples had a particularly low level and hence this was removed before 
normalisation. 
 
Illumina Infinium® Methylation 450K arrays 
Samples with a converted concentration of less than 10ng/µl were excluded from array 
processing. CpG site methylation was analysed at 485,577 sites using the Illumina Infinium 
HumanMethylation 450 Beadchip (450k).  This has been validated [21] and recently used to 
demonstrate differential methylation in relation to maternal smoking in pregnancy [8, 9].  4µl of 
bisulphite converted DNA was used and samples were processed according to the Illumina 
Infinium®HD Meth450 Protocol (Part No 15019522) and scanned on the Illumina iScan (San 
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Diego, CA).  Initial data QC was performed using the Genome Studio analysis package (Illumina 
(San Diego, CA)).  
 
Statistical analysis 
Raw intensity values extracted from the IDAT files were quantile normalised separately for each 
colour channel as well as probe type using a custom script. We remapped the genomic sequence 
of all probes to hg19 and removed those probes which mapped with >90% similarity to more 
than one genomic location as well as those probes which mapped to either chromosome X or Y. 
Furthermore we removed those probes which recorded intensity levels around background by 
using a detection p-value <0.01. This left 441,946 probes which were used for further analysis. 
We calculated beta values using the following equation [21] and used this as a measure of 
methylation across the 441,946 probes: 
𝛽 =
𝐼𝑚
𝐼𝑚 + 𝐼𝑢 + 100
  
 
where 𝐼𝑚 is the intensity in the methylated channel and 𝐼𝑢 is the intensity in the unmethylated 
channel. To ascertain how similar different tissue types are in terms of their methylation state we 
performed an unsupervised hierarchical clustering. We first calculated the Euclidean distance (d) 
between each of the samples by summing the square of the beta differences across all of the 
probes. Then we clustered the samples using a mean or average linkage. To further identify how 
close nasal, buccal and blood are in terms of methylation state to airway epithelium we first 
averaged the beta values of the samples for each tissue and then calculated the Euclidean 
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distance by summing the square of the differences between the average beta value of airway 





Characteristics of the children are shown in Table 1. One nasal sample and three buccal samples 
were insufficient for analysis, one blood sample was misplaced, and one sample failed bisulphite 
conversion, leaving 18 samples (plus 5 duplicate samples, i.e. 23 arrays in total) which were 
suitable for analysis.  
 
Figure 1 demonstrates the hierarchical clustering of the samples. Taking into account the 
441,946 probes for each sample, the diagram represents the difference in methylation at the same 
site in the DNA sequence between tissues.  The greater the distance (represented by height on the 
diagram), the greater the difference between tissues. This shows that the methylation profile of 
nasal epithelial cells was most similar to that of airway epithelial cells; the profile of buccal cells 
was moderately similar; that of blood was least similar. When we quantified this by calculating a 
standard Euclidean distance of the average methylation beta values for each tissue from the 
average value for airway epithelial cells, the distances for nasal, buccal and blood were, 
respectively, 46.1, 72.3, and 91.4. To further evaluate this we carried out a Wilcoxon rank sum 
test on the Euclidean distances for each sample of nasal, buccal and blood against the average 
methylation for airway epithelial cells. Both nasal (p-value = 0.004329) and buccal (p-value = 
0.009524) were significantly closer to airway epithelial cells than blood.  
 
Figure 2 demonstrates the extent of methylation for the 20,000 most variable probes (defined by 
having the largest variance in beta values across all of our samples), where yellow represents 
hypomethylation and blue represents hypermethylation; this gives a visual representation of the 
difference in methylation across the separate tissues, with blood clearly separate from the 
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respiratory tract samples. We analysed the blood cell type data for the same 20,000 variable 
probes analysed in Figure 2.  We found that nasal, airway and buccal cells clustered together as 
before, while whole blood clustered with the various blood subsets (data not shown), confirming 
that our conclusions above are not affected by blood cell type 
 
Figure 3 demonstrates the hierarchical clustering of the samples when we limited the analyses to 
children with asthma (n=3).  This confirmed a similar hierarchy of methylation profiles across 
tissues to that seen in all children.  Euclidean distances of the average methylation beta values 
for each tissue from the average value for airway epithelial cells, were 42.5, 84.2 and 92.8 for  





Asthma is primarily an epithelial disorder [22] and hence increasing our understanding of 
epigenetic changes in airway epithelium may shed light on asthma aetiology.  In epidemiological 
studies of the epigenetics of asthma, in which airway epithelial cells cannot be obtained, we 
therefore need to focus efforts on obtaining the most representative surrogate tissue.  In this 
study we have shown that nasal epithelial cells are a better proxy tissue than buccal cells for 
making inferences about epigenome-wide methylation patterns in airway epithelial cells, with 
blood being the worst proxy tissue.  Our findings suggest that, whilst studies to date which have 
measured DNA methylation in blood may have obtained some useful information, future studies 
of the epigenetics of asthma are likely to prove more informative if buccal cells, or preferably 
nasal epithelial cells, are collected.  We acknowledge, though, that blood DNA methylation 
profiling may still be informative for understanding epigenetic influences on the immune (atopic) 
component of asthma, as suggested by previous studies of Th1/Th2 gene methylation [23-25] or 
possibly in relation to DNA methylation changes induced by exposures that occur in utero or are 
inherited as a result of trans-generational transmission of DNA methylation. 
  
Our conclusion that blood methylation profiles may not be informative for making inferences 
about DNA methylation in the airway is supported by a recent study of children which compared 
DNA methylation profiles between  airway epithelial cells (AECs) and peripheral blood 
mononuclear cells (PMBCs)[26]. The authors demonstrated differential methylation of CpG sites 
in AECs compared with PBMCs, irrespective of disease phenotype, but nasal epithelial cells and 
buccal cells were not studied. Although we did not separate out PBMCs before DNA extraction 
in our study, and we did not take into account the differential white cell count in our analysis of 
DNA methylation in blood, it has recently been shown that polymorphonuclear leucocytes and 
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PBMCs do not differ in terms of methylation profiles [9]. Whilst it was recently proposed that 
nasal cell DNA may be a more appropriate and accessible proxy tissue for studying the 
epigenetics of asthma [27], airway epithelial cells and other proxy tissues were not compared in 
that study.   
 
A potential limitation of our study is that the sample size was small, as we experienced a number 
of refusals from parents because of concerns about taking airway brushings and prolonging the 
anaesthetic time. As our study includes children from multiple ethnic backgrounds, it cannot be 
excluded that ethnic differences may have influenced these findings. Despite this, by taking 
multiple samples from the same subject, we were able to demonstrate that a clear hierarchy of 
similarity between the methylation profiles of different proxy tissues and that of airway epithelial 
cells exists within individuals. Furthermore, a similar hierarchy was seen in children with 
asthma. Our nasal samples were acquired using a small curette which is an uncomfortable 
procedure when awake. Whilst tolerated well by adults it would be challenging to perform in 
younger children when not anaesthetised. Soft brushing of the nasal epithelium using a swab, as 
described by Baccarelli et al [27], offers an alternative technique for acquiring nasal epithelial 
cells in epidemiological studies, and may be more suitable especially in young children.  
 
In summary, we have shown that the best surrogate tissue for capturing methylation marks 
relevant to airway epithelium is the nasal epithelium, followed by buccal cells. DNA methylation 
profiling of blood samples does not accurately reflect the pattern of methylation seen in the 
airway. Future epidemiological studies of the role of DNA methylation in airways diseases 
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should take this into account, and existing or forthcoming data from studies based on 
methylation in blood should be interpreted with caution.  
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Legends for figures 
 
Figure 1: Hierarchical cluster dendrogram of DNA methylation by tissue type. The respiratory 
tract tissues cluster together, separately from blood. The dendrogram is calculated using 
agglomerative hierarchical clustering. The root of the dendrogram is at the top of the figure and 
its y-axis represents the Euclidean distance between clusters at each splitting point. A greater 
distance indicates greater differences between tissues. 
 
Figure 2: To visually inspect the data we took 20,000 probes with the highest variability across 
all samples. The rows of the heatmap represent an individual probe while the columns represent 
an individual sample. The beta value as recorded from the array is plotted from yellow to blue 
with yellow representing low methylation, green fractional methylation and blue high 
methylation. In the top part of the heatmap the respiratory tract tissues contain cytosines in the 
genome that are hypomethylated compared to blood. In the lower half of the heatmap the 
majority of probes are specifically hypomethylated in blood. 
 
Figure 3: Hierarchical cluster dendrogram of DNA methylation by tissue type restricted to 
children with asthma. 
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